Eduardo Hallak, partner, will participate in the “Life Science Strategy Summit on IP & Exclusivity”, which will take place from October 8th to 10th in Munich, Germany. Mr. Hallak will be one of the speakers on the panel "Global PTE/PTA Considerations: Essential Information to Commercialise International Life Science Products". The event will gather leading pharmaceutical and biotech professionals for three days of practical discussion on the protection of pharmaceutical drugs based on patent and regulatory exclusivities. Find out more at: https://lsstrategysummit.com/events/life-sciences-strategy-summit-ip-exclusivity

‍